Search bioRxivSearch

bioRxiv · 10.1101/189134

Reactive astrocytes - comprehending when neurons play 4’33”

Abstract

Homeostatic regulation is a powerful tool utilized by virtually all biological systems, brain included. Broadly speaking, each homeostatic process embodies two components: the sensing component, whereby a deviation is detected and quantified, and the effecting component that executes the homeostatic adjustment with the goal of alleviating the deviation. In the central nervous system, homeostatic plasticity has been suggested to play an important role in shaping the dynamics of single neurons and neuronal networks. However, existing \"biophysical\" models of homeostatic plasticity are exceedingly simplistic. These models usually describe the sensor component in terms of simple averaging over neuronal activity and offer no explanation of the relevant biochemical pathways. Here, we attempt to fill this gap in our understanding of homeostatic plasticity by proposing a biophysical framework to explain detection of prolonged synaptic inactivity that may occur in some scenarios of brain injury. We propose that sensing of, and response to, synaptic inactivity involves detection of the extracellular glutamate level and occurs via the activation of metabotropic glutamate receptors (mGluRs), while the inactivity-induced synthesis of one of the homeostatic plasticity effectors, tumor necrosis factor alpha (TNF), serves as an effecting component of the system. This model can help to explain the experimental observations linking prolonged neuronal inactivity to TNF signaling. Importantly, the proposed signaling scheme is not limited to mGluRs and astrocytes, but rather is potentially applicable to any cells expressing receptors that activate the relevant G protein units. The proposed signaling scheme is likely to be useful for developing pharmacological interventions targeting homeostatic plasticity pathways.\n\nAuthor summaryHomeostatic regulation refers to the self-regulation ability of a system aimed at remaining in the same (or nearly the same) state. Homeostatic plasticity, a form of homeostatic regulation that arises in the context of neural dynamics, has been shown to shape neuronal and network dynamics by attempting to maintain physiological levels of neuronal activity in brain networks. Thus, it changes the excitation-inhibition balance in a network when sufficiently large and long-lasting deviations from physiological levels of activity are detected. However, the biophysical mechanisms of homeostatic plasticity and in particular those related to the ability to sense neuronal inactivity, remain elusive. We propose a feasible biophysical model of a homeostatic sensor, in which the sensing of inactivity depends on the presence and activation of G-protein-coupled receptors with different activation thresholds. In this model, the activation of the higher-threshold receptor suppresses the detection of inactivity, while the activation of the lower-threshold receptor promotes the detection of inactivity. The proposed model helps to explain a growing body of experimental data relating synaptic inactivity to production of homeostatic plasticity effectors such as tumor necrosis factor alpha. Although we consider a specific case study of metabotropic glutamate receptors on astrocytes, the model conclusions are likely to be applicable to any cells expressing receptors that activate the relevant G protein units.

Explore related subjects

Keep this discovery

BibTeXRIS

Volman, V., Bazhenov, M.. 2017-09-14. Reactive astrocytes - comprehending when neurons play 4’33”. https://doi.org/10.1101/189134

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience